Molecular Assemblies: David Smoller and Stephen Turner

Enzymatic DNA synthesis company Molecular Assemblies has named David Smoller and Stephen Turner to its commercial-technology advisory board.

Smoller is a general partner of Cultivation Capital Life Sciences Fund, a venture fund focused on life science investing. He also serves as an entrepreneur in residence at St. Louis BioGenerator, the investment arm of BioSTL. He has also held leadership roles at Sigma-Aldrich and Genome Systems, and cofounded Solis Agrosciences, Panome Bio, and Canopy Biosciences (acquired by Bruker Corporation). His earlier ventures include Sage Labs (acquired by Horizon Discovery) and ProteoPlex.

Turner founded Pacific Biosciences and was a member of the project team at Cornell University that developed the technology now used by PacBio in its sequencers. He is the author of more than 300 scientific papers in fields such as DNA sequencing technology, biophysics, genomics, and epigenomics, and is listed as the inventor on more than 50 US patents and numerous published patent applications.